Envveno Medical Corporation (NVNO)

Apr 21, 2025

enVVeno Medical Corp appoints CBIZ CPAs as new auditor By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

enVVeno Medical Corp appoints CBIZ CPAs as new auditor - Investing.com Australia

Apr 21, 2025

Apr 16, 2025

enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment | NVNO Stock News - GuruFocus

Apr 16, 2025

Apr 16, 2025

enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment - Eagle-Tribune

Apr 16, 2025

Apr 16, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 16, 2025

Apr 16, 2025

Live Today: enVVeno Medical Unveils Game-Changing Venous Valve Technology - Stock Titan

Apr 16, 2025

Apr 07, 2025

enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer - ACCESS Newswire

Apr 07, 2025

Apr 06, 2025

Financial Analysis: ClearPoint Neuro (NASDAQ:CLPT) vs. enVVeno Medical (NASDAQ:NVNO) - Defense World

Apr 06, 2025

Apr 03, 2025

NVNO stock touches 52-week low at $2.45 amid market challenges - Investing.com

Apr 03, 2025

Apr 01, 2025

We're Hopeful That enVVeno Medical (NASDAQ:NVNO) Will Use Its Cash Wisely - simplywall.st

Apr 01, 2025

Mar 31, 2025

The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium - Weatherford Democrat

Mar 31, 2025

Mar 31, 2025

Virtu Financial LLC Buys Shares of 28,533 enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

Mar 31, 2025

Mar 24, 2025

NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain - MSN

Mar 24, 2025

Mar 13, 2025

VenoValve trial shows sustained patient benefits at 24 months - MSN

Mar 13, 2025

Mar 07, 2025

Sanctuary Advisors LLC Makes New Investment in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World

Mar 07, 2025

Mar 03, 2025

enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25 - BioSpace

Mar 03, 2025

Feb 28, 2025

enVVeno Medical (NVNO) to Release Earnings on Thursday - MarketBeat

Feb 28, 2025

Feb 28, 2025

enVVeno Medical expects capital to fund company through several milestones - TipRanks

Feb 28, 2025

Feb 28, 2025

enVVeno Medical Files For Mixed Shelf Of Up To $100 MillionSEC Filing - TradingView

Feb 28, 2025

Feb 28, 2025

enVVeno Medical reports FY24 EPS ($1.27) vs. ($1.91) last year - TipRanks

Feb 28, 2025

Feb 28, 2025

NVNOEnvveno Medical Corporation Latest Stock News & Market Updates - StockTitan

Feb 28, 2025

Feb 28, 2025

EnVVeno Medical Reports Fourth Quarter and Year-End 2024 Financi - News Channel Nebraska

Feb 28, 2025

Feb 28, 2025

Can enVVeno's $43M Cash Runway Carry VenoValve Through FDA Approval? Clinical Data Shows 78% Success Rate - Stock Titan

Feb 28, 2025

Feb 27, 2025

enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

enVVeno Medical (NVNO) Projected to Post Quarterly Earnings on Thursday - Defense World

Feb 27, 2025

Feb 26, 2025

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series - ACCESS Newswire

Feb 26, 2025

Feb 25, 2025

enVVeno Medical (NASDAQ:NVNO) Shares Up 6.4%Here's Why - MarketBeat

Feb 25, 2025

Feb 20, 2025

enVVeno Medical to Present at the Ladenburg Thalmann 2022 Healthcare Conference - ACCESS Newswire

Feb 20, 2025

Feb 20, 2025

One-year data from VenoValve US pivotal trial highlighting impact on patients’ QoL presented at AVF 2025 - Venous News

Feb 20, 2025

Feb 19, 2025

One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum - BioSpace

Feb 19, 2025

Feb 19, 2025

enVVeno Announces One Year Data from VenoValve U.S. Pivotal Trial - MPO-mag

Feb 19, 2025

Feb 19, 2025

enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - Milton Daily Standard

Feb 19, 2025

Feb 19, 2025

Can These 5 Growth Drivers Make enVVeno Medical the Next Big Thing in Venous Disease Treatment? - StockTitan

Feb 19, 2025

Feb 19, 2025

enVVeno Medical presents one-year data from VenoValve trial - TipRanks

Feb 19, 2025

Feb 19, 2025

Revolutionary Vein Treatment Shows Lasting Benefits: Will FDA Grant First-Ever Approval for Deep CVI? - StockTitan

Feb 19, 2025

Feb 08, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga India

Feb 08, 2025

Feb 07, 2025

VenoValve trial shows sustained patient benefits at 24 months By Investing.com - Investing.com South Africa

Feb 07, 2025

Feb 07, 2025

enVVeno Medical presents two-year follow-up data from VenoValve trial - TipRanks

Feb 07, 2025

Feb 07, 2025

Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting - ACCESS Newswire

Feb 07, 2025

Feb 07, 2025

VenoValve Clinical Trial Hits Home Run: 100% Patency Rate Stuns Medical Community - Stock Titan

Feb 07, 2025

Jan 27, 2025

enVVeno Medical to Present at the Virtual Investor 2022 Top Picks Conference - ACCESS Newswire

Jan 27, 2025

Jan 26, 2025

enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity - ACCESS Newswire

Jan 26, 2025

Jan 24, 2025

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024 - ACCESS Newswire

Jan 24, 2025

Jan 23, 2025

Westside Investment Management Inc. Acquires 116,650 Shares of enVVeno Medical Corporation (NASDAQ:NVNO) - MarketBeat

Jan 23, 2025

Jan 21, 2025

enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering - ACCESS Newswire

Jan 21, 2025